Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
22-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
22-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #30966
advertisement
Kim CY
19
Showing records 1 to 19 |
Display all abstracts from
Kim CY
96404
The Effect of CHIR 99021, a Glycogen Synthase Kinase-3β Inhibitor, on Transforming Growth Factor β-Induced Tenon Fibrosis
Lee SY
Investigative Ophthalmology and Visual Science
2021; 62: 25
96009
Effect of red ginseng on visual function and vision-related quality of life in patients with glaucoma
Lee K
Journal of ginseng research
2021; 45: 676-682
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kim JM
International Journal of Ophthalmology
2021; 14: 1539-1547
96440
Degree of Myopia and Glaucoma Risk: A Dose-Response Meta-analysis
Ha A; Kim CY
American Journal of Ophthalmology
2021; 236: 107-119
96404
The Effect of CHIR 99021, a Glycogen Synthase Kinase-3β Inhibitor, on Transforming Growth Factor β-Induced Tenon Fibrosis
Chae MK
Investigative Ophthalmology and Visual Science
2021; 62: 25
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Sung KR
International Journal of Ophthalmology
2021; 14: 1539-1547
96009
Effect of red ginseng on visual function and vision-related quality of life in patients with glaucoma
Yang H
Journal of ginseng research
2021; 45: 676-682
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Lee JW
International Journal of Ophthalmology
2021; 14: 1539-1547
96009
Effect of red ginseng on visual function and vision-related quality of life in patients with glaucoma
Kim JY
Journal of ginseng research
2021; 45: 676-682
96404
The Effect of CHIR 99021, a Glycogen Synthase Kinase-3β Inhibitor, on Transforming Growth Factor β-Induced Tenon Fibrosis
Yoon JS
Investigative Ophthalmology and Visual Science
2021; 62: 25
96440
Degree of Myopia and Glaucoma Risk: A Dose-Response Meta-analysis
Shim SR; Chang IB
American Journal of Ophthalmology
2021; 236: 107-119
96404
The Effect of CHIR 99021, a Glycogen Synthase Kinase-3β Inhibitor, on Transforming Growth Factor β-Induced Tenon Fibrosis
Kim CY
Investigative Ophthalmology and Visual Science
2021; 62: 25
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kyung H
International Journal of Ophthalmology
2021; 14: 1539-1547
96009
Effect of red ginseng on visual function and vision-related quality of life in patients with glaucoma
Choi W; Seong GJ
Journal of ginseng research
2021; 45: 676-682
96440
Degree of Myopia and Glaucoma Risk: A Dose-Response Meta-analysis
Kim YK
American Journal of Ophthalmology
2021; 236: 107-119
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Rho S
International Journal of Ophthalmology
2021; 14: 1539-1547
96009
Effect of red ginseng on visual function and vision-related quality of life in patients with glaucoma
Kim CY
Journal of ginseng research
2021; 45: 676-682
96352
Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial
Kim CY
International Journal of Ophthalmology
2021; 14: 1539-1547
96009
Effect of red ginseng on visual function and vision-related quality of life in patients with glaucoma
Lee JM; Bae HW
Journal of ginseng research
2021; 45: 676-682
Issue
22-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept